Table 2.
MBST | Hybrid | P value | |
ITT analysis | |||
Eradication rate | 91.4% (128/140) | 79.2% (114/144) | 0.013 |
95%CI | 90.2%-92.9% | 77.3%-80.7% | |
PP analysis | |||
Eradication rate | 94.1% (128/136) | 82.6% (114/138) | 0.003 |
95%CI | 92.9%-95.6% | 80.6%-84.1% |
ITT: Intention-to-treat; PP: Per-protocol; MBST: 14-d moxifloxacin-based sequential therapy; Hybrid: 14-d hybrid therapy.